Vivos (RDGL) Interest Coverage Ratio (QoQ) (2010 - 2021)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -28.47% |
| Sep 30, 2021 | 89.62% |
| Jun 30, 2021 | -694.20% |
| Mar 31, 2021 | 16.97% |
| Dec 31, 2020 | -140.72% |
| Sep 30, 2020 | -370.29% |
| Jun 30, 2020 | -661.01% |
| Mar 31, 2020 | -120.78% |
| Dec 31, 2019 | 138.28% |
| Sep 30, 2019 | 0.52% |
| Jun 30, 2019 | 68.53% |
| Mar 31, 2019 | 73.53% |
| Dec 31, 2018 | -3,277.26% |
| Sep 30, 2018 | -3,152.13% |
| Jun 30, 2018 | 84.72% |
| Mar 31, 2018 | -39.66% |
| Dec 31, 2017 | 82.20% |
| Sep 30, 2017 | -130.16% |
| Jun 30, 2017 | -14.74% |
| Mar 31, 2017 | -3,110.94% |
| Dec 31, 2016 | 100.30% |
| Sep 30, 2016 | 3.39% |
| Jun 30, 2016 | 42.06% |
| Mar 31, 2016 | -824.33% |
| Dec 31, 2015 | -829.01% |
| Sep 30, 2015 | 84.08% |
| Jun 30, 2015 | -0.66% |
| Mar 31, 2015 | -235.42% |
| Dec 31, 2014 | 77.73% |
| Sep 30, 2014 | -7.08% |
| Jun 30, 2014 | 9.18% |
| Mar 31, 2014 | -32.10% |
| Dec 31, 2013 | 16.41% |
| Sep 30, 2013 | 55.94% |
| Jun 30, 2013 | 22.85% |
| Mar 31, 2013 | -1.77% |
| Dec 31, 2012 | 48.13% |
| Sep 30, 2012 | 0.00% |
| Jun 30, 2012 | -42.51% |
| Mar 31, 2012 | 27.40% |
| Dec 31, 2011 | -23.74% |
| Sep 30, 2011 | 1.42% |
| Jun 30, 2011 | 23.37% |
| Mar 31, 2011 | -732.11% |
| Dec 31, 2010 | -119.92% |
| Sep 30, 2010 | 116.83% |